The capital enables KeyCare to scale its Epic‑native solution, giving health systems a faster path to virtual‑care adoption and strengthening its competitive edge in a rapidly expanding market.
The virtual‑care sector is entering a new phase of maturity, driven by patient demand for remote services and health systems’ need for seamless digital workflows. KeyCare’s Epic‑centric architecture differentiates it from generic telehealth platforms by embedding virtual visits directly into the electronic health record, reducing friction for clinicians and improving data continuity. This technical advantage positions the company to capture a larger share of the market as hospitals seek to modernize legacy systems without disrupting care delivery.
Funding for health‑tech startups has surged, but investors are increasingly favoring solutions that align with existing infrastructure. HealthX Ventures, 8VC, and other backers recognize that KeyCare’s integration with Epic—a dominant EHR platform—offers a defensible moat and clear path to revenue. The $27.4 million round, supplemented by strategic partners such as WellSpan and Allina Health, provides both capital and real‑world deployment sites, allowing KeyCare to refine its product, expand its sales force, and accelerate go‑to‑market initiatives across the United States.
For health systems, the infusion of capital translates into faster access to a proven virtual‑care model that can be rolled out at scale. By leveraging Epic’s data backbone, providers can deliver coordinated care, reduce readmissions, and meet value‑based reimbursement goals. As payers and regulators continue to incentivize remote care, KeyCare’s growth trajectory signals a broader industry shift toward integrated, EHR‑native telehealth solutions that promise both clinical and financial benefits.
KeyCare, a virtual care company built on Epic, announced the close of a $27.4 million financing round led by HealthX Ventures, with participation from 8VC, LRVHealth, BOLD Capital Partners and Ikigai Venture Partners, alongside strategic partners such as WellSpan Health and Exact Sciences. The funding brings the company's total capital raised to over $55 million.
Comments
Want to join the conversation?
Loading comments...